Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Parecoxib 40mg powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Drotrecogin alfa 5mg powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ertapenem 1g powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Caspofungin 50mg powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Caspofungin 70mg powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Dacarbazine 600mg powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Olanzapine 10mg powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Esomeprazole 40mg powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Dacarbazine 100mg powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Dacarbazine 500mg powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Dacarbazine 1g powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Generic Solivito N powder for concentrate for solution for infusion vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bortezomib 3.5mg powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Lepirudin 50mg powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Amphotericin (liposomal) 100mg powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Pemetrexed 500mg powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Disodium pamidronate 15mg powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Disodium pamidronate 30mg powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Disodium pamidronate 90mg powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Temocillin 1g powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Amphotericin (lipid formulation) 50mg powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Palifermin 6.25mg powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Daptomycin 350mg powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Urokinase 10,000unit powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Urokinase 50,000unit powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Urokinase 100,000unit powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Urokinase 250,000unit powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Urokinase 500,000unit powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Botulinum toxin type A 50unit powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Botulinum toxin type A 100unit powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cytomegalovirus immunoglobulin human 3g powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cytomegalovirus immunoglobulin human 3g powder for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Human cytomegalovirus immunoglobulin 3g powder for solution for injection vials (Scottish National Blood Transfusion Service) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Human cytomegalovirus immunoglobulin 3g powder for solution for injection vials (Scottish National Blood Transfusion Service) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Dacarbazine 200mg powder for solution for injection vials (Medac GMBH) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Dacarbazine 200mg powder for solution for injection vials 12 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Fortum Monovial 2g powder for solution for injection vials (GlaxoSmithKline) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Tigecycline 50mg powder for solution for injection vials 10 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Tygacil 50mg powder for solution for injection vials (Wyeth Laboratories) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Tygacil 50mg powder for solution for injection vials (Wyeth Laboratories) 10 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Tigecycline 50mg powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ampicillin 500mg powder for solution for injection vials (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ampicillin 500mg powder for solution for injection vials (A A H Pharmaceuticals Ltd) 10 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Dacarbazine 200mg powder for solution for injection vials 10 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Dacarbazine 200mg powder for solution for injection vials (Medac GMBH) 10 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Co-amoxiclav 500mg/100mg powder for solution for injection vials (Teva UK Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Co-amoxiclav 500mg/100mg powder for solution for injection vials (Teva UK Ltd) 10 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Co-amoxiclav 1000mg/200mg powder for solution for injection vials (Teva UK Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Co-amoxiclav 1000mg/200mg powder for solution for injection vials (Teva UK Ltd) 10 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Doxorubicin 10mg powder for solution for injection vials 10 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Doxorubin 10mg powder for solution for injection vials (medac UK) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Doxorubin 10mg powder for solution for injection vials (medac UK) 10 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Doxorubicin 50mg powder for solution for injection vials 10 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Doxorubin 50mg powder for solution for injection vials (medac UK) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Doxorubin 50mg powder for solution for injection vials (medac UK) 10 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Daunorubicin 20mg powder for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Levothyroxine sodium 500microgram powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Levothroid 500microgram powder for solution for injection vials (Aventis Pharma) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Levothyroxine sodium 500microgram powder for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Levothroid 500microgram powder for solution for injection vials (Aventis Pharma) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Alglucosidase alfa 50mg powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Myozyme 50mg powder for concentrate for solution for infusion vials (Sanofi Genzyme) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Alglucosidase alfa 50mg powder for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Myozyme 50mg powder for concentrate for solution for infusion vials (Sanofi Genzyme) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Levothyroxine sodium 200microgram powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Levothyroxine sodium 200microgram powder for solution for injection vials (American Pharmaceutical Partners, Inc) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Levothyroxine sodium 200microgram powder for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Levothyroxine sodium 200microgram powder for solution for injection vials (American Pharmaceutical Partners, Inc) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Oxaliplatin 50mg powder for solution for infusion vials (Mayne Pharma Plc) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Oxaliplatin 100mg powder for solution for infusion vials (Mayne Pharma Plc) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Oxaliplatin 50mg powder for solution for infusion vials (Mayne Pharma Plc) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Oxaliplatin 100mg powder for solution for infusion vials (Mayne Pharma Plc) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Funnel web spider venom antiserum 125units powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Botulinum antitoxin 700mg powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Botulinum antitoxin 700mg powder for solution for injection vials (Special Order) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Funnel web spider antivenom 125unit powder for solution for injection vials (CSL Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Funnel web spider venom antiserum 125units powder for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Botulinum antitoxin 700mg powder for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Botulinum antitoxin 700mg powder for solution for injection vials (Special Order) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Funnel web spider antivenom 125unit powder for solution for injection vials (CSL Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Daptomycin 500mg powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cubicin 500mg powder for concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Oxaliplatin 50mg powder for solution for injection vials (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Oxaliplatin 100mg powder for solution for injection vials (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Daptomycin 500mg powder for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cubicin 500mg powder for concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Oxaliplatin 50mg powder for solution for injection vials (A A H Pharmaceuticals Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Oxaliplatin 100mg powder for solution for injection vials (A A H Pharmaceuticals Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Fibrinogen 1g powder for solution for injection bottles |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Haemocomplettan P 1g powder for solution for injection bottles (ZLB Behring UK Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Fibrinogen 1g powder for solution for injection bottles 1 bottle |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Haemocomplettan P 1g powder for solution for injection bottles (ZLB Behring UK Ltd) 1 bottle |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Urokinase 25,000unit powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Syner-KINASE 100,000unit powder for solution for injection vials (Syner-Med (Pharmaceutical Products) Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Syner-KINASE 25,000unit powder for solution for injection vials (Syner-Med (Pharmaceutical Products) Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Urokinase 25,000unit powder for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Syner-KINASE 100,000unit powder for solution for injection vials (Syner-Med (Pharmaceutical Products) Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Syner-KINASE 25,000unit powder for solution for injection vials (Syner-Med (Pharmaceutical Products) Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Generic Crofab snake venom antiserum 1g powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Crofab snake venom antiserum 1g powder for solution for injection vials (Protherics Inc) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Desferal 500mg powder for solution for injection vials (Waymade Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|